Bundling case against Amgen wins magistrate blessing
Amgen should face allegations it illegally monopolised the market for a type of cholesterol drug through anticompetitive rebates, a federal magistrate judge has said.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10